前收市價 | 1.4000 |
開市 | 1.4000 |
買盤 | 0.6000 |
賣出價 | 1.5000 |
拍板 | 15.00 |
到期日 | 2024-12-20 |
今日波幅 | 1.4000 - 1.4000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 31 |
Bicycle Therapeutics (BCYC) gains 10% upon entering a PIPE financing agreement with multiple institutional investors, which is expected to generate gross proceeds of $555 million.
The consensus price target hints at an 85.5% upside potential for Bicycle Therapeutics (BCYC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Ocugen (OCGN) have performed compared to their sector so far this year.